Suchard Jeffrey, Nizkorodov Sergey, Wilkinson Stacy
Department of Emergency Medicine, University of California, Irvine Medical Center, Orange, CA, USA.
J Med Toxicol. 2009 Sep;5(3):120-4. doi: 10.1007/BF03161221.
The U.S. Consumer Product Safety Commission announced a recall of Aqua Dots (Spin Master Ltd.; Toronto, Canada) on November 7, 2007 due to children becoming ill after swallowing beads from these toy craft kits. Reports suggested that the beads contained 1,4-butanediol (1,4-BD), a precursor to gamma-hydroxybutyrate (GHB), rather than the intended, but more expensive 1,5-pentanediol (1,5-PD). We measured the 1,4-BD and 1,5-PD content of Aqua Dots beads to determine if 1,5-PD had been completely substituted with 1,4-BD by the manufacturer, and if the reported clinical effects from swallowing Aqua Dots beads were consistent with the estimated ingested 1,4-BD dose.
In vitro bench research using gas chromatography-mass spectroscopy (GC-MS) was performed. Dilute samples of pure 1,4-BD and 1,5-PD in water were used for the calibration of the GC-MS instrument. We then soaked Aqua Dots beads in water for varying durations, and the resultant solutions were analyzed for 1,4-BD and 1,5-PD content.
Aqua Dots beads weighed 79.3 mg each (+/- 0.6 mg, SD), and contained 13.7% (+/- 2.4%, SD) 1,4-BD by weight; this corresponds to a 1,4-BD content of 10.8 mg (+/- 1.9 mg, SD) per bead. No 1,5-PD was detected in any beads.
Aqua Dots beads contained a surprisingly high amount (nearly 14%) of extractable 1,4-BD. No 1,5-PD was detected, corroborating reports that this chemical had been completely replaced with a substitute that is metabolized into GHB after ingestion. Reports of ataxia, vomiting, seizure activity, and self-limited coma in children are consistent with the ingestion of several dozen Aqua Dots beads.
2007年11月7日,美国消费品安全委员会宣布召回水精灵(Spin Master有限公司;加拿大多伦多),原因是儿童吞食这些玩具手工套件中的珠子后生病。报告表明,珠子中含有的是1,4 - 丁二醇(1,4 - BD),它是γ - 羟基丁酸(GHB)的前体,而非原本使用的但更昂贵的1,5 - 戊二醇(1,5 - PD)。我们测量了水精灵珠子中1,4 - BD和1,5 - PD的含量,以确定制造商是否已将1,5 - PD完全替换为1,4 - BD,以及吞食水精灵珠子后报告的临床症状是否与估计摄入的1,4 - BD剂量相符。
采用气相色谱 - 质谱联用(GC - MS)进行体外实验研究。使用在水中稀释的纯1,4 - BD和1,5 - PD样品对GC - MS仪器进行校准。然后将水精灵珠子在水中浸泡不同时长,对所得溶液分析1,4 - BD和1,5 - PD的含量。
每个水精灵珠子重79.3毫克(±0.6毫克,标准差),按重量计含有13.7%(±2.4%,标准差)的1,4 - BD;这相当于每个珠子的1,4 - BD含量为10.8毫克(±1.9毫克,标准差)。在任何珠子中均未检测到1,5 - PD。
水精灵珠子中可提取的1,4 - BD含量出奇地高(近14%)。未检测到1,5 - PD,这证实了有关该化学品已被完全替换为摄入后会代谢为GHB的替代物的报告。儿童出现共济失调、呕吐、癫痫活动和自限性昏迷的报告与吞食几十颗水精灵珠子的情况相符。